252 results
Page 3 of 13
8-K
EX-99.1
nb0ish zeenveiiufjr
16 May 22
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
72sw0 6l9hrr3
31 Mar 22
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update
5:02pm
8-K
EX-14.1
irh 33nujns
18 Feb 22
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:43pm
8-K
EX-99.1
0yji05wio61ga s2mkf
10 Jan 22
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
4:31pm
8-K
3128jtjee4ccvxodftf
10 Jan 22
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
4:31pm
8-K
EX-99.1
06bce7a131z
22 Nov 21
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
5:00pm
8-K
EX-99.1
qmu r73r24rt7l0
18 Oct 21
Adamis Receives FDA Approval for ZIMHI
4:41pm
8-K
EX-99.1
ptae9kfi7o
24 Aug 21
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
5:06pm
DEFA14A
epusu43tv4j
13 Jul 21
Additional proxy soliciting materials
8:27am
DEFA14A
5ipla6 gs08q1mtbsmi9
13 Jul 21
Additional proxy soliciting materials
6:04am
8-K
EX-99.1
zapxcd 1jm0re
13 Jul 21
Investor Presentation July 2021
6:02am
DEFA14A
kbc1 c53e
1 Jul 21
Additional proxy soliciting materials
8:20am
DEFA14A
8hzcqnjgq
28 Jun 21
Additional proxy soliciting materials
7:31am
DEFA14A
ynm72vofd6 asfv3e4
14 Jun 21
Additional proxy soliciting materials
10:32am
8-K
EX-99.1
0kv2fhajob27
15 Apr 21
Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
5:03pm